Telaprevir

CHEMBL231813 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

679.8 g/mol

LogP

4.2

Phase

4

This antiviral medication was used as part of combination therapy to treat chronic hepatitis C infection caused by genotype 1 of the virus. It works by blocking an enzyme (protease) that the hepatitis C virus needs to replicate. It has largely been replaced by newer, better-tolerated hepatitis C treatments.

Moleküler Ağırlık

679,8000 g/mol

LogP

4,20

TPSA

180,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

HIV/AIDS Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1

InChI

InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1

Molecular Formula

C36H53N7O6

HBD / HBA

4 / 8

Döndürülebilir Bağlar

14

Ağır Atomlar

49

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This antiviral medication was used as part of combination therapy to treat chronic hepatitis C infection caused by genotype 1 of the virus. It works by blocking an enzyme (protease) that the hepatitis C virus needs to replicate. It has largely been replaced by newer, better-tolerated hepatitis C treatments.

Yes, Telaprevir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL231813. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3010818. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Telaprevir PillFYI'da

Yapı

Hızlı Veriler

Formül: C36H53N7O6

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.